EGFR-TKI Therapy Prolongs Survival In Non-small Cell Lung Cancer Patients With Brain Metastases or Bone Metastases

被引：0
|
作者：
Hui, L. [1 ]
Xiaomei, G. [1 ]
Wei, J. [2 ]
Chunxue, B. [1 ]
Zhaochong, Z. [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Shanghai 200433, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.1853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 50 条
  • [1] Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases
    Miyawaki, Eriko
    Kenmotsu, Hirotsugu
    Mori, Keita
    Harada, Hideyuki
    Mitsuya, Koichi
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakasu, Yoko
    Gon, Yasuhiro
    Takahashi, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (03): : 604 - 613
  • [2] Early Radiation Therapy Combined With EGFR-TKI Is Associated With Longer Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases
    Liu, Y.
    Deng, L.
    Zhou, X.
    Zhou, L.
    Xu, Y.
    Gong, Y.
    Wang, J.
    Lu, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E436 - E436
  • [3] Icotinib, an EGFR-TKI, for the treatment of brain metastases in non-small cell lung cancer:a retrospective study
    Qunhui Wang
    Hua Zheng
    Ying Hu
    Baohua Lu
    Fanbin Hu
    Hongmei Zhang
    Baolan Li
    [J]. Oncology and Translational Medicine, 2016, 2 (06) : 268 - 274
  • [4] The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancer
    Xu Yufen
    Song Binbin
    Chen Wenyu
    Liu Jialiang
    Yang Xinmei
    [J]. SPRINGERPLUS, 2016, 5
  • [5] Treatment outcomes of EGFR-TKI with or without locoregional brain therapy in advanced EGFR-mutant non-small cell lung cancer patients with brain metastases
    Linh, Do Mai
    Thinh, Tran Huy
    Hieu, Nguyen-Van
    Duc, Nguyen Minh
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (02): : 71 - 79
  • [6] Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer
    Grant, Christopher
    Nagasaka, Misako
    [J]. CANCER TREATMENT REVIEWS, 2024, 126
  • [7] EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
    Fan, Yun
    Xu, Xiaoling
    Xie, Conghua
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 2075 - 2084
  • [8] Efficacy of EGFR-TKI therapy in patients with brain metastases from non-small-cell lung cancer: A meta-analysis
    Zhang, Wei
    Hu, Lijuan
    Huang, Caihong
    Ying, Jun
    Zhao, Naiqing
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (11) : 2761 - 2772
  • [9] Effect of Osimertinib in Non-Small Cell Lung Cancer Patients with Brain Metastases After Progression Following Front-Line EGFR-TKI Therapy
    Yu, X.
    Fan, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S400 - S400
  • [10] Survival in patients with non-small cell lung cancer and brain metastases
    Lwin, M. Thit
    Bradley, K.
    Wright, S.
    Laurence, V.
    [J]. LUNG CANCER, 2010, 67 : S32 - S32
12345